Fibroblast Activation Protein (FAP) – A promising target for radiopharmaceuticals
Join Dr. Sherly Mosessian, SOFIE's Chief Scientific Officer to discuss the Fibroblast Activation Protein (FAP)- A promising target for radiopharmaceuticals.
Join Dr. Sherly Mosessian, SOFIE's Chief Scientific Officer to discuss the Fibroblast Activation Protein (FAP)- A promising target for radiopharmaceuticals.
Visit SOFIE at the upcoming meeting from June 11 - 14, 2022 in Vancouver, Canada at Booth #319.
Presenter: Kimon Jackson, MSMP, MSA, CNMT Clinical Account Executive for SOFIE A Nuclear Medicine Technologist [...]
Visit SOFIE at the upcoming meeting from September 28 - October 1, 2022 in Miami, FL.
Visit SOFIE at the upcoming meeting from September 30 – October 2, 2022 in Bonita Springs, FL.
Visit SOFIE at the upcoming meeting from October 7 - 9, 2022 in Kansas City, KS.
Presenter: Dr. Robert Bridwell, MD, MBA Medical Advisor at SOFIE Dr. Robert Bridwell, medical advisor [...]
Visit SOFIE at the upcoming meeting from November 4 - 6, 2022 in Groton, CT.
In this webinar, Ms. Grabher will help you to understand the complex process companies go through when getting a radiopharmaceutical FDA approved.
Visit SOFIE at the upcoming Northern California Chapter SNMMI Annual Meeting on February 16, 2023 in Pleasanton, CA.
Visit SOFIE at The Future of Radiopharmaceuticals: Targeted Theranostic Therapeutics (digital conference)
Visit SOFIE at the upcoming Mid-Eastern Chapter of SNMMI Meeting from April 14-16, 2023 in Linthicum Heights, MD.